Efficacy and tolerability of long-acting risperidone in patients previously treated with opal atypical antipsychotics

被引：0
|
作者：
Schreiner, A
Moeller, HJ
机构：
[1] Janssen Cilag Neuss, Neuss, Germany
[2] Univ Munich, Dept Psychiat, Munich, Germany
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone
    Schmauss, Max
    Sacchetti, Emilio
    Kahn, Jean-Pierre
    Medori, Rossella
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 85 - 92
  • [2] Satisfaction of patients and caregivers with long-acting injectable risperidone and oral atypical antipsychotics
    Han, CS
    Lee, BH
    Kim, YK
    Lee, HJ
    Kim, SH
    Kim, L
    Lee, MS
    Joe, SH
    Ham, BJ
    Jung, IK
    [J]. PRIMARY CARE & COMMUNITY PSYCHIATRY, 2005, 10 (03) : 119 - 124
  • [3] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF RISPERIDONE LONG-ACTING INJECTABLE AND ORAL ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC PATIENTS: TWO YEAR NATURALISTIC STUDY
    Lbach, Bernd
    Rabinowitz, Jonathan
    Schreiner, Andreas
    Hargarter, Ludger
    Diekamp, Bettina
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 527 - 527
  • [4] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF RISPERIDONE LONG-ACTING INJECTABLE AND ORAL ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC PATIENTS: TWO YEAR NATURALISTIC STUDY
    Ibach, B.
    Rabinowitz, J.
    Schreiner, A.
    Hargarter, L.
    Diekamp, B.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [5] EFFICACY AND TOLERABILITY AMONG PATIENTS WITH RECENT ONSET SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG-ACTING INJECTABLE (RLAI)
    Napryeyenko, Oleksandr
    Burba, Benjaminas
    Martinez, Guadalupe
    Neznanov, Nikolay
    Fischel, Tsvi
    Bayle, Franck
    Corrivetti, Giulio
    Smeraldi, Enrico
    Rabinowitz, Jonathan
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 496 - 496
  • [6] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [7] Improved symptom control with risperidone long-acting injectable in psychotic patients previously treated with an oral atypical antipsychotic
    Glue, P
    Chrzanowski, W
    Kissling, W
    Buccomino, D
    Medori, R
    Parellada, E
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S79
  • [8] Risperidone long-acting injectable in elderly psychotic patients: assessment of tolerability and efficacy
    Simpson, S
    Heise, M
    Kontis, K
    Glue, P
    Medori, R
    Kissling, W
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 364 - 364
  • [9] EFFECTIVENESS, TOLERABILITY AND COMPLIANCE OF SCHIZOPHRENIC PATIENTS UNDER TREATMENT WITH ORAL ATYPICAL ANTIPSYCHOTICS OR LONG-ACTING INJECTABLE RISPERIDONE IN DAILY ROUTINE
    Schreiner, A.
    Ibach, B.
    Hargarter, L.
    Diekamp, B.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [10] Long-acting, injectable risperidone a direct transition from oral atypical antipsychotics
    Schmauss, M
    Schreiner, A
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S76 - S76
12345